Archibiome tattoo for resistant, responsive, and resilient cities

The REMEDY project aims to revolutionize architecture with engineered living materials that enhance building resilience and aesthetics through custom microbial inks, promoting a probiotic approach to design.

Subsidie
€ 2.998.122
2025

Projectdetails

Introduction

The REMEDY project proposes a game-changing technology in the form of an archibiome tattoo that will allow bespoke and high-resolution decoration and functionalisation of new and existing buildings. Our ambition is to achieve a breakthrough in fundamental research in microbiology and synthetic biology, transfer the know-how to materials science in the form of engineered living materials, and develop compatible biofabrication processes that allow personalised design in the architectural context.

Customisation of Building Appearance

We propose the customisation of building appearance with living and active interkingdom microbial inks that will act similarly to probiotic skincare products, enhancing biotherapeutic architecture. The tailored and engineered microbial consortia will create a beneficial microbiome, providing:

  • Resilience and resistance against pathogenic microorganisms
  • Carbon sequestration
  • Oxygen production
  • Bioremediation

among others.

Evaluation and Analysis

We will use the latest metagenomic tools to evaluate the functionome of the created microbial consortia along every step in the development of living inks. In silico analysis will be applied to predict combinations of microorganisms based on genome-scale models of metabolism.

Machine Learning Implementation

Machine learning models will be implemented for predictive analysis of growth patterns and structural outcomes, providing insights for further optimising ink formulations and printing parameters.

Impact on the Building Industry

REMEDY will introduce metabolic thinking in the circular building industry, boost probiotic architecture, and initiate a microbial revolution that aims to change the negative perception of microorganisms in architecture. The “high-risk” idea proposed by the interdisciplinary consortium will deliver a “high-gain” solution in the form of probiotic architecture.

A New Dimension in Materials

REMEDY will provide a new dimension that has not yet existed for conventional materials – life. It will change the way we perceive, experience, understand, design, use, and transform materials.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.998.122
Totale projectbegroting€ 2.998.122

Tijdlijn

Startdatum1-2-2025
Einddatum31-1-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • INNORENEW COE CENTER ODLICNOSTI ZA RAZISKAVE IN INOVACIJE NA PODROCJU OBNOVLJIVIH MATERIALOV IN ZDRAVEGA BIVANJSKEGA OKOLJApenvoerder
  • UNIVERZA V LJUBLJANI
  • TECHNISCHE UNIVERSITAET GRAZ
  • TIGER Coatings
  • XYLOTRADE B.V.
  • QRES TECHNOLOGIES SRO

Land(en)

SloveniaAustriaNetherlandsSlovakia

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

Bacteria Biofilm as bio-factory for tissue regeneration

BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.

€ 2.903.862
EIC Pathfinder

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

€ 1.718.408
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

€ 2.805.403
EIC Pathfinder

Digital design and robotic fabrication of biofoams for adaptive mono-material architecture

The ARCHIBIOFOAM project aims to develop multifunctional, 3D-printable biofoams with programmable properties for sustainable architecture, enhancing performance while reducing CO2 emissions.

€ 3.422.982
EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

€ 2.606.250

Vergelijkbare projecten uit andere regelingen

ERC Consolid...

Bioinspired living skin for architecture

The ARCHI-SKIN project aims to develop a bioactive protective coating using fungal biofilms to enhance the durability and functionality of various materials through innovative design and in-situ methods.

€ 1.999.000
ERC Proof of...

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

€ 150.000
ERC Consolid...

Additive Manufacturing of Living Composite Materials

This project aims to create living composites by integrating biological systems into engineering materials, enhancing adaptability, healing, and performance through innovative fabrication techniques.

€ 1.999.491
Mkb-innovati...

InnomABs

IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.

€ 14.888
EIC Transition

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.

€ 2.499.999